Enrolled Bill Summary

House Bill 810	House Author:  Parker et al.
Effective:  9-1-17	Senate Sponsor:  Bettencourt et al.

            House Bill 810 amends the Health and Safety Code to establish the eligibility of a patient with a severe chronic disease or terminal illness to access and use an investigational stem cell treatment. The bill sets out requirements for such treatment and creates a Class A misdemeanor offense for a person who knowingly offers to buy, offers to sell, acquires, receives, sells, or otherwise transfers any adult stem cells for valuable consideration for use in an investigational stem cell treatment, with certain exceptions.